Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Feng Zhao

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Cellular and Infection Microbiology|July 3, 2026
Exploratory model-based optimizing isavuconazole dosing regimens for <i>Aspergillus</i> spp. in adult patients according to serum albumin levels: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulationXiao-Chen Wei, Ming-Feng Zhao, Hai-Rong Lyu, et al.
Journal of Global Antimicrobial Resistance|November 29, 2024
Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulationXiao-Chen Wei, Ming-Feng Zhao, Hai-Rong Lv, et al.
Oncology Letters|February 10, 2015
Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case reportQi Deng, Jing-Yi Li, Peng-Jiang Liu, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2013
[Epidemiology of invasive fungal disease in patients with hematological diseases]Xue-mei Lin, Qi Deng, Ming-feng Zhao, et al.
The Journal of International Medical Research|August 25, 2023
Ileus induced by the combination of vinca alkaloids and posaconazole in a patient with acute lymphoblastic leukemia: a case report and literature reviewYue Li, Yin-Hua Gong, Ming-Feng Zhao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 17, 2020
[Clinical Effectiveness of Decitabine Combined with Reduced FLAG Regimen in the Treatment of Senile Patients with High-Risk Acute Myeloid Leukemia]Yao Qi, Ming-Feng Zhao, Xia Xiao, et al.
HLA|February 25, 2024
The novel HLA-C*12:02:52 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individualYe-di Pu, Zhi-Cong Xie, Li Ma, et al.
Current Treatment Options in Oncology|October 23, 2023
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid LeukemiaShujing Guo, Xuejin Gao, Mahara Sadhana, et al.
Oncology Reports|April 4, 2019
Effect and changes in PD‑1 expression of CD19 CAR‑T cells from T cells highly expressing PD‑1 combined with reduced‑dose PD‑1 inhibitorRui Zhang, Qi Deng, Yan-Yu Jiang, et al.
Experimental and Therapeutic Medicine|March 18, 2015
Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathwaysQ I Deng, Xue Bai, Hai-Rong Lv, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Cellular and Infection Microbiology|July 3, 2026
Exploratory model-based optimizing isavuconazole dosing regimens for <i>Aspergillus</i> spp. in adult patients according to serum albumin levels: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulationXiao-Chen Wei, Ming-Feng Zhao, Hai-Rong Lyu, et al.
Journal of Global Antimicrobial Resistance|November 29, 2024
Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulationXiao-Chen Wei, Ming-Feng Zhao, Hai-Rong Lv, et al.
Oncology Letters|February 10, 2015
Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case reportQi Deng, Jing-Yi Li, Peng-Jiang Liu, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2013
[Epidemiology of invasive fungal disease in patients with hematological diseases]Xue-mei Lin, Qi Deng, Ming-feng Zhao, et al.
The Journal of International Medical Research|August 25, 2023
Ileus induced by the combination of vinca alkaloids and posaconazole in a patient with acute lymphoblastic leukemia: a case report and literature reviewYue Li, Yin-Hua Gong, Ming-Feng Zhao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 17, 2020
[Clinical Effectiveness of Decitabine Combined with Reduced FLAG Regimen in the Treatment of Senile Patients with High-Risk Acute Myeloid Leukemia]Yao Qi, Ming-Feng Zhao, Xia Xiao, et al.
HLA|February 25, 2024
The novel HLA-C*12:02:52 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individualYe-di Pu, Zhi-Cong Xie, Li Ma, et al.
Current Treatment Options in Oncology|October 23, 2023
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid LeukemiaShujing Guo, Xuejin Gao, Mahara Sadhana, et al.
Oncology Reports|April 4, 2019
Effect and changes in PD‑1 expression of CD19 CAR‑T cells from T cells highly expressing PD‑1 combined with reduced‑dose PD‑1 inhibitorRui Zhang, Qi Deng, Yan-Yu Jiang, et al.
Experimental and Therapeutic Medicine|March 18, 2015
Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathwaysQ I Deng, Xue Bai, Hai-Rong Lv, et al.
Pageof 5